BridgeMD
New treatment option for Preterm Birth
Official title E-health-supported Diagnostic and Intervention in Preterm Born Children and Their Families
ClinicalTrials.gov ID: NCT06939192
What this study is testing
- What it's testing
- The app-based diagnostic and support approach with a focus on mental and somatic symptoms is intended to strengthen the resilience of premature born children and families and to identify risk and resilience factors.The overall objective of the study is to improve the post-inpatient care of families with premature born children. The procedure is evaluated by a two-arm design with an experimental group and a TAU group.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 to 34. Healthy volunteers may be eligible.
You may be able to join if
- Premature babies born at the UKT,
- Gestational age 28-34 weeks,
- Mother: age ≥ 18 years,
- agreement to participate in this study and signing of a consent form,
- sufficient knowledge of German,
You likely can't join if
- Premature babies \ 34th week of pregnancy,
- at least one of the children has serious diseases of the nervous system or obvious symptoms of a nervous disease,
- at least one of the children has serious congenital diseases or suffers from malformations,
- Mother: Lack of access to a smartphone/tablet,
- no internet access,
- insufficient knowledge of German
See the full eligibility criteria
- Premature babies born at the UKT,
- Gestational age 28-34 weeks,
- Mother: age ≥ 18 years,
- agreement to participate in this study and signing of a consent form,
- sufficient knowledge of German,
- internet access
- Premature babies \ 34th week of pregnancy,
- at least one of the children has serious diseases of the nervous system or obvious symptoms of a nervous disease,
- at least one of the children has serious congenital diseases or suffers from malformations,
- Mother: Lack of access to a smartphone/tablet,
- no internet access,
- insufficient knowledge of German
The study team makes the final eligibility decision.
Where it's taking place
- Tübingen, Baden-Wurttemberg, Germany
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 28 weeks to 34 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tübingen, Baden-Wurttemberg, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.